The Effect of a Psycho-Educational Program on Psychiatric Symptoms, Drug Attitude and Treatment Satisfaction of Patients with Schizophrenia

The purpose of this study was to determine the effect of a Comprehensive Psycho-Educational Ap-proach and Scheme Set (COMPASS) for patients with schizophrenia who were treated with rispe-ridone long-acting injectable (RLAI), on their psychiatric symptoms, drug attitudes, and treatment satisfaction levels. Participants were sixty-five patients at thirteen hospitals in Japan who met ICD-10 F2 criteria for schizophrenia or schizo-affective disorder and were treated with RLAI. A correlational study design was used to measure the effect of the COMPASS on the psychiatric symp-toms, drug attitudes, and treatment satisfaction levels of patients treated with RLAI. Using the fol-lowing evaluation indicators: The Subjective Satisfaction to Treatment Scale (SSTS), Brief Psychia-tric Rating Scale (BPRS), Global Assessment of Functioning (GAF), Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS), and Drug Attitude Inventory-10 (DAI-10), measurements were taken at the beginning of the program (baseline), at the end of the program, and six months after (end-point). Data analysis included descriptive statistics, Mann-Whitney U test or Wilcoxon signed